Create Free Account

By creating account you will get access to hot stocks & personalised emails

IDT Australia Ltd

Healthcare AU IDT

0.091AUD
-0.004(4.21%)

Last update at 2024-05-02T03:44:00Z

Day Range

0.090.10
LowHigh

52 Week Range

0.050.12
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -9.77600M -1.87600M 0.97M -1.98100M -6.11900M
Minority interest - - - - -
Net income -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Selling general administrative 9.78M 7.08M 12.31M 11.77M 12.56M
Selling and marketing expenses - - - - -
Gross profit 4.75M 10.66M 14.15M 12.49M 9.26M
Reconciled depreciation 1.04M 1.54M 1.78M 2.03M 2.52M
Ebit -9.87300M -1.90100M 0.07M -0.57600M -5.56500M
Ebitda -8.83400M -0.36500M 1.85M 1.46M -3.04700M
Depreciation and amortization 1.04M 1.54M 1.78M 2.03M 2.52M
Non operating income net other - - - - -
Operating income -9.77600M -1.87600M 0.97M -1.24500M -5.56500M
Other operating expenses -6.02600M -4.48000M -4.82400M -12.93200M 17.70M
Interest expense - 0.03M 0.90M 1.41M 0.02M
Tax provision -1.27800M -0.71600M -1.13700M -0.06200M -0.03600M
Interest income - - 0.03M 0.07M 0.02M
Net interest income - - 0.03M 0.07M 0.22M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.27800M -0.71600M -1.13700M -0.06200M -0.03600M
Total revenue 6.93M 12.11M 16.03M 14.10M 11.88M
Total operating expenses 14.63M 12.57M 14.09M 13.80M 15.07M
Cost of revenue 2.18M 1.44M 1.87M 1.61M 2.62M
Total other income expense net 0.10M 0.03M 0.87M -0.73600M -0.55400M
Discontinued operations - - - - -
Net income from continuing ops -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Net income applicable to common shares -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 28.29M 30.08M 34.13M 28.59M 31.20M
Intangible assets 0.00000M 0.00000M 0.12M 0.25M 1.11M
Earning assets - - - - -
Other current assets 0.19M 0.05M 1.76M 0.03M 0.02M
Total liab 4.15M 3.09M 6.51M 5.29M 6.19M
Total stockholder equity 24.14M 26.99M 27.61M 23.30M 25.01M
Deferred long term liab - - 0.12M 0.25M 1.11M
Other current liab 0.83M 0.15M 2.47M 4.51M 4.37M
Common stock 54.93M 51.19M 51.19M 51.19M 51.19M
Capital stock 54.93M 51.19M 51.19M 51.19M 51.19M
Retained earnings -41.56100M -32.70000M -31.54000M -33.64300M -31.72400M
Other liab 0.17M 0.31M 0.45M 0.34M 1.23M
Good will - - - - -
Other assets - - 0.12M 0.25M 1.11M
Cash 4.43M 9.21M 6.93M 6.86M 9.50M
Cash and equivalents - - - - -
Total current liabilities 3.98M 2.78M 6.07M 4.95M 4.96M
Current deferred revenue 2.07M 1.19M 0.25M 0.04M 0.15M
Net debt -3.69300M -8.33300M -6.16200M -6.85500M -9.48800M
Short term debt 0.74M 0.88M 0.77M 0.00500M 0.00400M
Short long term debt 0.74M 0.88M 0.77M - -
Short long term debt total 0.74M 0.88M 0.77M 0.00500M 0.00900M
Other stockholder equity -13.36800M -18.12600M -19.64900M -17.54600M 5.54M
Property plant equipment 18.55M 16.21M 16.74M 15.53M 16.68M
Total current assets 9.74M 13.87M 17.27M 12.81M 13.42M
Long term investments - - - - -
Net tangible assets 24.14M 26.99M 27.61M 23.30M 25.01M
Short term investments - - - - -
Net receivables 2.25M 1.54M 8.12M 5.44M 3.23M
Long term debt - - - - 0.00500M
Inventory 1.37M 1.10M 0.45M 0.44M 0.66M
Accounts payable 0.35M 0.55M 2.58M 0.40M 0.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 10.77M 8.50M 7.97M 5.75M 5.54M
Additional paid in capital - - - - -
Common stock total equity - - - 51.19M 51.19M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -18.54600M -16.21500M - - 17.78M
Deferred long term asset charges - - - - -
Non current assets total 18.55M 16.21M 16.86M 15.77M 17.78M
Capital lease obligations - - - 0.00500M 0.00900M
Long term debt total 0.00000M 0.00000M 0.00000M 0.00000M 0.00500M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.52200M -0.91200M -0.52600M -0.76100M -0.87100M
Change to liabilities -1.18600M -1.25400M 0.64M -0.25900M 0.68M
Total cashflows from investing activities -0.52200M -0.91200M -0.52600M -0.76100M -0.87100M
Net borrowings -0.14100M 0.02M 0.02M -0.00400M -0.53300M
Total cash from financing activities 3.64M 0.34M 0.22M 0.01M -2.14300M
Change to operating activities 0.20M 0.28M -0.01000M 0.07M -0.08800M
Net income -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Change in cash -4.78100M 2.29M 0.07M -2.63700M -4.53000M
Begin period cash flow 9.21M 6.93M 6.86M 9.50M 14.03M
End period cash flow 4.43M 9.21M 6.93M 6.86M 9.50M
Total cash from operating activities -7.90200M 2.86M 0.37M -1.91000M -1.51600M
Issuance of capital stock 3.78M 0.32M 0.20M 0.02M 0.03M
Depreciation -1.03900M -1.53600M 1.78M 1.91M 2.52M
Other cashflows from investing activities - 0.00000M 0.00000M 0.00000M 0.33M
Dividends paid - - - - -
Change to inventory 0.27M -0.69800M -0.00900M 0.19M 0.07M
Change to account receivables 1.00M 7.10M -3.92000M -2.18000M 0.24M
Sale purchase of stock 3.78M 0.32M 0.20M 0.02M -1.64400M
Other cashflows from financing activities 1.23M 1.35M 1.09M -0.00400M -0.53300M
Change to netincome 0.18M 0.32M 0.28M 0.19M 0.78M
Capital expenditures 0.52M 0.91M 0.53M 0.76M 1.20M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.27M 6.40M -3.92900M -1.99000M 0.25M
Stock based compensation 0.18M 0.32M 0.31M 0.19M -
Other non cash items 1.63M 5.56M -3.51300M -1.90300M 3.56M
Free cash flow -8.42400M 1.95M -0.15600M -2.67100M -1.20100M

Fundamentals

  • Previous Close 0.10
  • Market Cap33.39M
  • Volume20929
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.85000M
  • Revenue TTM10.33M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 1.64M
  • Diluted EPS TTM-0.02

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDT
IDT Australia Ltd		 -0.004 4.21% 0.09 - - 3.03 1.36 2.87 -4.252
AFP
AFT Pharmaceuticals Ltd		 -0.02 0.72% 2.77 31.00 17.06 1.79 4.41 2.18 16.66
PBP
Probiotec Ltd		 -0.03 1.05% 2.83 28.30 - 1.06 2.64 1.39 8.58
VLS
Vita Life Sciences Ltd		 -0.02 0.87% 2.27 13.35 - 1.73 2.97 1.41 7.98
NXS
Next Science Ltd		 -0.005 1.54% 0.32 - 128.21 4.47 5.03 3.90 -5.9908

Reports Covered

Stock Research & News

View All

Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

IDT Australia Ltd

45 Wadhurst Drive, Boronia, VIC, Australia, 3155

Key Executives

Name Title Year Born
Mr. Paul McDonald Interim CEO NA
Mr. Chris Kagiaros Head of People & Culture NA
Dr. David Sparling BVSc (Hons), GDipAppCGov, L.L.B., LLB (Hons) Joint company Sec. NA
Mr. Vasanthakumar Mahendran Interim Chief Financial Officer NA
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Company Sec. 1964
Mr. Paul Anthony McDonald Chief Executive Officer NA
Mr. Vasanthakumar Mahendran Chief Financial Officer NA
Mr. Jim Sosic COO & Operations Director NA
Ms. Priscilla Thiyageas Quality Director NA
Ms. Paula Coutts Head of People & Safety NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.